Join Piers Nash, biochemist, cancer biologist and Booth MBA as he explores data-driven personalized medicine and the challenges of standardized data at the multi-petabyte scale.
Event Details
Genomic data holds the potential to more accurate diagnosis of cancers, determine prognosis, and provide the basis for individualized treatment recommendations – a paradigm commonly referred to as Precision Medicine. At the Center for Data Intensive Science at The University of Chicago, we have developed the National Cancer Institute Genomic Data Commons (GDC). This represents the largest unified data repository for standardized and homogenized cancer genomic data ever assembled. By enabling data sharing across cancer genomic studies, we seek to democratize access and accelerate discovery in support of precision medicine as part of the Cancer Moonshot initiative. We will discuss the challenges of standardized data at multi-petabyte scale, health data as a national resource, and the market potential for precision medicine analytics.
Registration
Register Online
Registration closes at 12pm on 11/3. You may register at the door. Please have exact cash ($10) or check.
Deadline: 11/3/2016
Speaker Profiles
Piers Nash, MBA, PhD (Speaker) '14
Director of Business Development & Outreach, University of Chicago
https://cdis.uchicago.edu/
A biochemist and cancer biologist with 20 years of academic experience, Piers joined the faculty at The University of Chicago in 2004. He authored over 50 academic publications in journals such as Nature, Science and Molecular Cell, before moving on from research to focus on enterprise-level business strategy and pursue an MBA at The Booth School of Business. Piers joined the Center for Data Intensive Science in December 2014 to promote corporate and academic partnerships aimed at developing the infrastructure and analytic tools for data-driven personalized medicine.
Questions
Roger Moore, '92
Senior Director / Gartner